Macrolides versus placebo for chronic asthma

Overview of attention for article published in Cochrane database of systematic reviews, November 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 68 X posts from 62 X users, with an upper bound of 211,943 followers.

アレルギー学会成人喘息におけるマクロライド系抗菌薬の有効性と安全性（SR/meta）高知大学　大西先生 https://t.co/vOyIefPmP5 →小児を含む喘息ではマクロライド持続投与で重症の増悪の減少と症状改善の報告あり

RT @ajv67: Macrólidos versus placebo para el asma crónica - Undela, K - 2021 | Cochrane Library https://t.co/LyUENts9BZ

Macrólidos versus placebo para el asma crónica - Undela, K - 2021 | Cochrane Library https://t.co/LyUENts9BZ

RT @FarmaMadridAP: Seguridad y eficacia de macrólidos frente a placebo en asma crónica. https://t.co/3ICEssmSCg vía @rincondesisifo

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 64 additional X posts.